We are live on
!
Find out more
TRCT
Tower Research Capital (TRC) Portfolio holdings
AUM
$4.08B
1-Year Est. Return
58.77%
This Fund
S&P 500
This Quarter
Est. Return
+26.23%
1 Year Est. Return
+58.77%
3 Year Est. Return
+143.94%
5 Year Est. Return
+167.17%
10 Year Est. Return
+536.06%
AUM
$2.44B
AUM Growth
+$792M
(+48%)
Cap. Flow
+$442M
Cap. Flow
% of AUM
18.15%
Top 10 Holdings %
Top 10 Hldgs %
14.39%
Holding
5,222
New
2,059
Increased
1,821
Reduced
839
Closed
374
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
iPath Series B S&P 500 VIX Short-Term Futures ETN
VXX
|
+$55.3M |
| 2 |
Apple
AAPL
|
+$33.2M |
| 3 |
Amazon
AMZN
|
+$29.2M |
| 4 |
Microsoft
MSFT
|
+$26.4M |
| 5 |
Direxion Daily Semiconductor Bull 3X ETF
SOXL
|
+$22.1M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
State Street SPDR S&P 500 ETF Trust
SPY
|
+$342M |
| 2 |
iShares MSCI EAFE ETF
EFA
|
+$93.3M |
| 3 |
iShares MSCI Emerging Markets ETF
EEM
|
+$86M |
| 4 |
iShares Russell 2000 ETF
IWM
|
+$51.5M |
| 5 |
State Street Utilities Select Sector SPDR ETF
XLU
|
+$29.6M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 12.14% |
| 2 | Healthcare | 9.57% |
| 3 | Financials | 8.79% |
| 4 | Industrials | 7.76% |
| 5 | Consumer Discretionary | 7.68% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
3201
Hudbay
HBM
$12.3B
| $41K | ﹤0.01% |
13,743
+5,023
| +58% | +$12.6K |
|
3202
Hess Midstream
HESM
$5.2B
| $41K | ﹤0.01% |
+2,198
| New | +$36.7K |
|
3203
Investar Holding Corp
ISTR
$417M
| $41K | ﹤0.01% |
+2,856
| New | +$36.4K |
|
3204
Direxion Daily S&P Biotech Bull 3X ETF
LABU
$638M
| $41K | ﹤0.01% |
35
-681
| -95% | -$591K |
|
3205
LifeVantage
LFVN
$84M
| $41K | ﹤0.01% |
3,068
+2,968
| +2,968% | +$41.2K |
|
3206
LG Display
LPL
$3.43B
| $41K | ﹤0.01% |
8,557
-1,658
| -16% | -$7.56K |
|
3207
Puma Biotechnology
PBYI
$453M
| $41K | ﹤0.01% |
+3,944
| New | +$40.8K |
|
3208
Patterson-UTI
PTEN
$4.22B
| $41K | ﹤0.01% |
11,683
+7,757
| +198% | +$26.7K |
|
3209
RGC Resources
RGCO
$222M
| $41K | ﹤0.01% |
+1,679
| New | +$42.7K |
|
3210
SCYNEXIS
SCYX
$48M
| $41K | ﹤0.01% |
+675
| New | +$45.8K |
|
3211
TransAlta
TAC
$3.95B
| $41K | ﹤0.01% |
+6,999
| New | +$40.2K |
|
3212
Weibo
WB
$1.93B
| $41K | ﹤0.01% |
+1,232
| New | +$42.3K |
|
|
WSR
3213
DELISTED
Whitestone REIT
WSR
| $41K | ﹤0.01% |
+5,695
| New | +$36.2K |
|
|
MTVA
3214
MetaVia Inc
MTVA
$7.33M
| $41K | ﹤0.01% |
+2
| New | +$72.3K |
|
|
MCBC
3215
DELISTED
Macatawa Bank Corp
MCBC
| $41K | ﹤0.01% |
+5,199
| New | +$37.6K |
|
|
TRVN
3216
DELISTED
Trevena, Inc.
TRVN
| $41K | ﹤0.01% |
44
+18
| +69% | +$12K |
|
|
NYMX
3217
DELISTED
Nymox Pharmaceutical Corp
NYMX
| $41K | ﹤0.01% |
+11,547
| New | +$36.5K |
|
|
STSA
3218
DELISTED
Satsuma Pharmaceuticals, Inc. Common Stock
STSA
| $41K | ﹤0.01% |
+1,413
| New | +$32.7K |
|
|
ZNGA
3219
DELISTED
ZYNGA INC. CL A COMMON
ZNGA
| $41K | ﹤0.01% |
4,243
+1,070
| +34% | +$8.78K |
|
|
TPCO
3220
DELISTED
Tribune Publishing Company Common Stock
TPCO
| $41K | ﹤0.01% |
4,135
+4,035
| +4,035% | +$36.2K |
|
3221
Astronics
ATRO
$3.7B
| $40K | ﹤0.01% |
+4,600
| New | +$36K |
|
3222
AXT Inc
AXTI
$4.83B
| $40K | ﹤0.01% |
+8,403
| New | +$39.6K |
|
3223
Braskem
BAK
$881M
| $40K | ﹤0.01% |
4,630
+1,612
| +53% | +$13.9K |
|
3224
BayCom
BCML
$341M
| $40K | ﹤0.01% |
3,110
+2,190
| +238% | +$27.1K |
|
3225
Bank of Montreal
BMO
$127B
| $40K | ﹤0.01% |
742
-2,270
| -75% | -$116K |
|
Similar funds
CA
BHC
ICP
AP
BWA
BOK
JSW
SP
Tower Research Capital (TRC)'s Q2 2020 Portfolio in Review
As of Q2 2020, Tower Research Capital (TRC) held 5,222 positions worth $2.44B, up 48% from $1.64B the previous quarter. Its ten largest holdings account for 14% of the portfolio.
Tower Research Capital (TRC) deployed $442M of net new capital in Q2 2020, opening 2,059 new positions and adding to 1,821 existing holdings. Its largest new stake was Apple: 428,252 shares worth $39.1M.
By sector, the portfolio is most concentrated in Technology at 12% of assets, up from 3.1% a quarter earlier, followed by Healthcare and Financials.
On the sell side, the largest reduction was State Street SPDR S&P 500 ETF Trust, an estimated $342M trimmed.
- Tower Research Capital (TRC)'s largest Q2 2020 buy was Apple: 428,252 shares worth $39.1M.
- Tower Research Capital (TRC) added most to iPath Series B S&P 500 VIX Short-Term Futures ETN in Q2 2020, an estimated $55.3M increase.
- Tower Research Capital (TRC)'s biggest Q2 2020 reduction was State Street SPDR S&P 500 ETF Trust, cutting an estimated $342M.
- Tower Research Capital (TRC) fully exited First Trust Technology AlphaDEX Fund in Q2 2020, selling an estimated $2.52M.
- Tower Research Capital (TRC)'s ten largest holdings make up 14% of its $2.44B portfolio in Q2 2020.
- Tower Research Capital (TRC) opened 2,059 new positions and closed 374 in Q2 2020.
- Tower Research Capital (TRC)'s portfolio value rose 48% quarter-over-quarter to $2.44B.
Based on Tower Research Capital (TRC)'s 13F filing for Q2 2020, filed 13 Aug 2020.